Xiong Lillian, Dupuy Damian E
Department of Diagnostic Imaging, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI.
J Thorac Imaging. 2016 Jul;31(4):228-37. doi: 10.1097/RTI.0000000000000212.
Lung cancer had an estimated incidence of 221,200 in 2015, making up 13% of all cancer diagnoses. Tumor ablation is an important treatment option for nonsurgical lung cancer and pulmonary metastatic patients. Radiofrequency ablation has been used for over a decade with newer modalities, microwave ablation, cryoablation, and irreversible electroporation presenting as additional and possibly improved treatment options for patients. This minimally invasive therapy is best for small primary lesions or favorably located metastatic tumors. These technologies can offer palliation and sometimes cure of thoracic malignancies. This article discusses the current available technologies and techniques available for tumor ablation.
2015年肺癌的估计发病率为221,200例，占所有癌症诊断病例的13%。肿瘤消融是无法进行手术的肺癌患者和肺转移患者的重要治疗选择。射频消融已经使用了十多年，而较新的方式，如微波消融、冷冻消融和不可逆电穿孔，为患者提供了更多且可能更好的治疗选择。这种微创治疗最适合小的原发性病变或位置有利的转移性肿瘤。这些技术可以缓解症状，有时还能治愈胸部恶性肿瘤。本文讨论了目前可用于肿瘤消融的技术和方法。
